Wall Street Hits Record Highs As Rate Cut Bets Offset Shutdown: This Week In Markets - Pfizer ( NYSE:PFE )
Wall Street soared to fresh record highs at the end of the week, brushing aside the 21st U.S. government shutdown in history and a missing jobs report, as investors doubled down on bets for interest rate cuts and cheered strong gains in pharmaceutical and AI-driven tech stocks.
Illumina to Join Pharma Partners for CDx Development on KRAS Biomarker
ILMN partners with pharma leaders to advance KRAS-focused companion diagnostics through its TruSight Oncology platform.
Quest Diagnostics Joins Forces With Epic to Improve Laboratory Testing
DGX teams up with Epic on Project Nova to streamline lab testing, boost efficiency, and enhance patient and provider experiences.
Thermo Fisher Scientific Shares Up 3.3% After Power Inflow Signal - Thermo Fisher Scientific ( NYSE:TMO )
Thermo Fisher Scientific Inc ( NYSE:TMO ) experienced a significant Power Inflow alert, a key bullish indicator that is closely tracked by traders who value order flow analytics, specifically institutional and retail order flow data.
Thermo Fisher Launches Four-Part Bond Offering Ahead Of Possible Government Shutdown - Thermo Fisher Scientific ( NYSE:TMO )
Thermo Fisher Scientific Inc. ( NYSE:TMO ) is tapping the U.S. investment-grade bond market with a four-part, dollar-denominated offering, as companies move to secure funding ahead of a potential U.S. government shutdown.
PacBio Enters Carrier Screening Market With PureTarget Expansion
PACB expands its PureTarget portfolio, streamlining carrier screening with HiFi sequencing to meet rising global demand.
QuidelOrtho Expands Portfolio With the Launch of FDA-Approved Test
QDEL boosts its respiratory testing lineup with the FDA-cleared QUICKVUE Influenza + SARS Test for professional use.
Beat the Market the Zacks Way: Helios Technologies, InterDigital, UnitedHealth in Focus
Helios Technologies, InterDigital and UnitedHealth shine as Zacks' strategies deliver strong gains across model portfolios.
Check Out What Whales Are Doing With TMO - Thermo Fisher Scientific ( NYSE:TMO )
Financial giants have made a conspicuous bullish move on Thermo Fisher Scientific. Our analysis of options history for Thermo Fisher Scientific TMO revealed 12 unusual trades. Delving into the details, we found 58% of traders were bullish, while 16% showed bearish tendencies.
Chromatography Technologies Powering the Future of Biopharmaceuticals
Boston, Sept. 23, 2025 ( GLOBE NEWSWIRE ) -- According to the latest study from BCC Research, the "Chromatography in Pharmaceuticals and Biotechnology: Global Markets" is projected to grow from $13.3 billion in 2025 to $19.8 billion by the end of 2030, at a compound annual growth rate ( CAGR ) ...
HOLX vs. TMO: Which Diagnostic Giant Is the Stronger Buy Today?
Diagnostic leaders Hologic and Thermo Fisher post raised outlooks, acquisitions and strong product momentum.
Hologic's Strong International Traction to Continue Despite Headwinds
HOLX's global push shows strength, with surgical growth and rising diagnostics use offsetting near-term challenges.
Banzai to Present at the Emerging Growth Conference on Wednesday, September 24, 2025
Banzai to Present at the Emerging Growth Conference on Wednesday, September ...
Chinese biotech start-up challenging US dominance aims for IPO in 2027
Shuimu BioSciences, a Chinese start-up specialising in advanced imaging devices for viruses and smaller biomolecules, is aiming for an initial public offering in 2027 after selling its first self-developed product this year, according to CEO Allen Guo Chunlong.
The New Olink Target 48 Neurodegeneration Panel May Boost TMO Stock
Thermo Fisher unveils the Olink Target 48 Neurodegeneration panel to accelerate biomarker research in neurodegenerative diseases.
Harvard Bioscience Expands Distribution Agreement with Fisher Scientific to Include United States - Harvard Bioscience ( NASDAQ:HBIO )
HOLLISTON, Mass., Sept. 16, 2025 ( GLOBE NEWSWIRE ) -- Harvard Bioscience, Inc.
Beat the Market the Zacks Way: CommScope, Micron, Oracle in Focus
Zacks' strategies continue to outpace the market in 2025, with standout gains from CommScope, Micron, Oracle, and others across multiple model portfolios.
Minnesota Rep. Kelly Morrison Sold Up to $305K Worth of Accenture Stock - Thermo Fisher Scientific ( NYSE:TMO ) , Accenture ( NYSE:ACN )
A report on September 11, 2025 shows that Representative Kelly Morrison from Minnesota sale stock in Accenture ACN, valued between $67,011 and $305,000. According to the September filing, the transaction occurred on August 19, 2025. At the time of writing, Accenture shares are trading down 1.24% ...
Aon To Rally Around 19%? Here Are 10 Top Analyst Forecasts For Thursday - Aon ( NYSE:AON ) , AvalonBay Communities ( NYSE:AVB )
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. Wells Fargo raised W. P. Carey Inc. WPC price target from $68 to $72.
This Thermo Fisher Scientific Analyst Turns Bullish; Here Are Top 4 Upgrades For Thursday - Aon ( NYSE:AON ) , AvalonBay Communities ( NYSE:AVB )
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page. Deutsche Bank analyst Lee Horowitz upgraded Chewy, Inc. CHWY from Hold to Buy and announced a ...
Banzai Completes $32.7 Million Debt and Liability Elimination Through August 31, 2025
Banzai Completes $32.7 Million Debt and Liability Elimination Through August ...
Banzai Completes $32.7 Million Debt and Liability Elimination Through August 31, 2025 - Banzai International ( NASDAQ:BNZI )
$10.7 Million Repaid Year to Date and $32.7 Million Since September 2024 Obligation Debt Reduction Initiatives Adding Material Benefit to Net Income and Shareholders' Equity SEATTLE, Sept. 05, 2025 ( GLOBE NEWSWIRE ) -- Banzai International, Inc.
Banzai Completes $32.7 Million Debt and Liability Elimination Through August 31, 2025
Banzai Completes $32.7 Million Debt and Liability Elimination Through August ...
DNA Manufacturing Market to Hit USD 19.56 Billion by 2032 as Demand for Cell and Gene Therapies Continues to Rise
Burlingame, CA, Sept. 04, 2025 ( GLOBE NEWSWIRE ) -- The Global DNA Manufacturing Market is estimated to be valued at USD 6.44 Bn in 2025 and is expected to reach USD 19.56 Bn by 2032, exhibiting a compound annual growth rate ( CAGR ) of 17.2% from 2025 to 2032.
Hologic's Panther Fusion Signals More Molecular Diagnostics Upside
HOLX's Panther Fusion expands its diagnostics menu, fueling assay growth and unlocking more upside in molecular testing.
Bio-Techne Stock Upgraded As Analyst Flags Attractive Entry Point - Bio-Techne ( NASDAQ:TECH )
RBC Capital upgraded Bio-Techne to Outperform and lifted its price target from $61 to $73. Bio-Techne shares are down 26% over the past year and 25% year-to-date. Get Discounted Real-Time Trade Alerts For a Volatile Market ( Labor Day Special )
Why Is Idexx ( IDXX ) Down 0.4% Since Last Earnings Report?
Idexx (IDXX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Banzai to Present at the H.C. Wainwright 27th Annual Global Investment Conference on September 8, 2025
Banzai to Present at the H.C. Wainwright 27th Annual Global Investment Conference on September ...
Why Thermo Fisher Scientific Stock Tumbled Today
Investors seemed unhappy about some major spending news from the company.
Beat the Market the Zacks Way: Oracle, Intellia, Pharming Group in Focus
Even in a choppy market, Zacks' strategies are spotlighting winners like Oracle, Intellia, and Pharming Group, proving the value of a disciplined, research-driven approach.
Price Over Earnings Overview: Thermo Fisher Scientific - Thermo Fisher Scientific ( NYSE:TMO )
Looking into the current session, Thermo Fisher Scientific Inc. TMO shares are trading at $492.72, after a 0.61% spike. Moreover, over the past month, the stock went up by 5.64%, but in the past year, fell by 18.75%.
Hologic ( HOLX ) Down 0.3% Since Last Earnings Report: Can It Rebound?
Hologic (HOLX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Should You Continue to Hold Thermo Fisher Stock in Your Portfolio?
TMO's growth, driven by new partnerships and strong end markets, faces challenges from macro pressures and fierce competition.
$100 Invested In This Stock 20 Years Ago Would Be Worth This Much Today - Thermo Fisher Scientific ( NYSE:TMO )
Thermo Fisher Scientific TMO has outperformed the market over the past 20 years by 6.79% on an annualized basis producing an average annual return of 15.43%. Currently, Thermo Fisher Scientific has a market capitalization of $185.14 billion.
[Latest] Global Chemical Reagents Market Size/Share Worth USD 26.5 Billion by 2034 at a 7.5 CAGR: Custom Market Insights ( Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis )
Austin, TX, USA, Aug. 25, 2025 ( GLOBE NEWSWIRE ) -- Custom Market Insights has published a new research report titled "Chemical Reagents Market Size, Trends and Insights By Product Type ( Solvents, Acids & Bases, Oxidizing & Reducing Agents, Buffers & Standards, Catalysts ) , By Application ( ...
Biobanking Market is expected to generate a revenue of USD 2.11 Billion by 2031, Globally, at 9.89% CAGR: Verified Market Research®
Lewes, Delaware, Aug. 25, 2025 ( GLOBE NEWSWIRE ) -- The Global Biobanking Market Size is projected to grow at a CAGR of 9.89% from 2024 to 2031, according to a new report published by Verified Market Research®.
Thermo Fisher ( TMO ) Up 1.8% Since Last Earnings Report: Can It Continue?
Thermo Fisher (TMO) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
[Latest] Global Induced Pluripotent Stem Cells Production Market Size/Share Worth USD 4.34 Billion by 2034 at a 9.5% CAGR: Custom Market Insights ( Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT )
Austin, TX, USA, Aug. 22, 2025 ( GLOBE NEWSWIRE ) -- Custom Market Insights has published a new research report titled "Induced Pluripotent Stem Cells Production Market Size, Trends and Insights By Process ( Manual iPSC Production, Automated iPSC Production ) , By Workflow ( Cell Culture, Cell ...
Genome Editing Market to Grow at 16.9% CAGR Through 2030
Boston, Aug. 20, 2025 ( GLOBE NEWSWIRE ) -- According to the latest study from BCC Research, the "Genome Editing: Technologies and Global Markets" is projected to grow from $10.8 billion in 2025 to $23.7 billion by the end of 2030, at a compound annual growth rate ( CAGR ) of 16.9% during the ...
Why Thermo Fisher Scientific Stock Was Topping the Market Today
According to one pundit, the company has a hard-to-beat mix of quality products and services.
Thermo Fisher Positioned As Biopharma's Partner Of Choice - Thermo Fisher Scientific ( NYSE:TMO )
Thermo Fisher stock is projected to reach $598 by 2026, offering 22% upside. Shares have fallen 27% since 2021, trailing the S&P's 30% gain, but the long-term outlook is strong. Get more market-moving news first with AI-powered analysis that turns noise into opportunity.
Biodesix Recognized as a Thermo Fisher Scientific Center of Excellence ( COE ) for NGS Diagnostics
Biodesix recently validated Thermo Fisher's tissue-based Oncomine Dx Express Test for solid tumors on the Genexus Dx Integrated Sequencer Biodesix recently validated Thermo Fisher's tissue-based Oncomine Dx Express Test for solid tumors on the Genexus Dx Integrated Sequencer ...
This Thermo Fisher Scientific Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday - AeroVironment ( NASDAQ:AVAV ) , Celestica ( NYSE:CLS )
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.
The Zacks Analyst Blog Highlights IBM, Goldman Sachs Group and Thermo Fisher Scientific
IBM, Goldman Sachs and Thermo Fisher stand out in Zacks research with AI growth, strong banking results and new product launches.
Astrotech Corporation Appoints Nihanth Badugu as Chief Operating Officer
AUSTIN, Texas, Aug. 18, 2025 ( GLOBE NEWSWIRE ) -- Astrotech Corporation ( Nasdaq: ASTC ) ( the "Company" or "Astrotech" ) , today announced that it has appointed Nihanth Badugu as Chief Operating Officer ( "COO" ) of the Company. Mr. Badugu's appointment is effective as of August 13, 2025.
A Closer Look at Thermo Fisher Scientific's Options Market Dynamics - Thermo Fisher Scientific ( NYSE:TMO )
Investors with a lot of money to spend have taken a bearish stance on Thermo Fisher Scientific TMO. We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga. Whether these are institutions or just wealthy individuals, we don't know.
Beat the Market the Zacks Way: CBRE, Acadian, Fastenal in Focus
CBRE, Acadian, and Fastenal highlight Zacks' market-beating picks as portfolios outpace broader indexes with strong 2025 gains.
TMO Receives FDA Approval for Oncomine Dx Target Test
Thermo Fisher secures FDA approval for its Oncomine Dx Target Test to identify NSCLC patients eligible for HERNEXEOS treatment.
Here's How Much a $1000 Investment in Thermo Fisher Scientific Made 10 Years Ago Would Be Worth Today
Why investing for the long run, especially if you buy certain popular stocks, could reap huge rewards.
Toast, Amazon, Thermo Fisher Scientific On CNBC's 'Final Trades' - TransDigm Gr ( NYSE:TDG ) , Amazon.com ( NASDAQ:AMZN )
On CNBC's "Halftime Report Final Trades," Ritholtz Wealth Management CEO Joshua Brown named Toast, Inc. TOST following the release of quarterly results. On Aug. 5, the company reported quarterly earnings of 13 cents per share. It exceeded the analyst consensus estimate of 11 cents per share.
